HALO AP

Indica Labs Receives FDA Clearance for HALO AP Dx Digital Pathology Platform for Use with Hamamatsu Images Acquired with the NanoZoomer® S360MD Slide Scanner

Albuquerque, NM, and Hamamatsu City, Japan – 22 May, 2024 – Indica Labs, an industry leader in AI-powered digital pathology solutions, and Hamamatsu Photonics K.K., a pioneer in whole slide imaging systems, announce that the U.S. Food and Drug Administration (FDA) has issued a 510(k) clearance to Indica Labs for HALO AP Dx, an enterprise digital pathology platform.

Indica Labs Receives FDA Clearance for HALO AP Dx Digital Pathology Platform for Use with Hamamatsu Images Acquired with the NanoZoomer® S360MD Slide Scanner Read More »

Merge by Merative Partners with Indica Labs to Bring Digital Pathology into Enterprise Imaging Solutions

Ann Arbor, MI and Albuquerque, NM – 27 November 2023 – Merge by Merative, an industry leader in medical imaging solutions, signed an agreement with Indica Labs, a leading provider of AI-powered digital pathology solutions. This partnership will enable healthcare organizations to seamlessly integrate digital pathology into Merge imaging solutions.

Merge by Merative Partners with Indica Labs to Bring Digital Pathology into Enterprise Imaging Solutions Read More »

Indica Labs Launches Comprehensive Management Service for HALO® Software in AWS Cloud-Hosted Environments

Albuquerque, NM – 8 June 2023 – Indica Labs today announces the launch of a service offering deployment and on-going support of its HALO® digital pathology software in a fully managed cloud-hosted environment powered by Amazon Web Services (AWS).

Indica Labs Launches Comprehensive Management Service for HALO® Software in AWS Cloud-Hosted Environments Read More »

Indica Labs and Lunit Announce a Strategic Alliance for Seamless Integrated Digital Pathology AI Workflows

Albuquerque, NM and Seoul, South Korea – 25 April 2023 – Indica Labs, an industry leader in quantitative digital pathology and image management innovations, and Lunit, a leading medical AI software platform company focused on cancer biomarkers announced an agreement to provide a fully interoperable solution between Indica Labs’ HALO AP® image management software platform and Lunit’s suite of AI pathology products. The combined solution is already in use at Guardant Health, a leading precision oncology company.

Indica Labs and Lunit Announce a Strategic Alliance for Seamless Integrated Digital Pathology AI Workflows Read More »

Molecular and Digital Pathology Innovators Xyall and Indica Labs Forge Global Collaboration to Transform Precision Oncology Workflows

Albuquerque, USA and Eindhoven, The Netherlands – April 17th, 2023 – Xyall and Indica Labs have entered into a global strategic partnership designed to bridge the gap between histology and molecular pathology. It unites Xyall’s unique automated tissue dissection solutions with Indica Labs’ AI-powered, diagnostic digital pathology platform. 

Molecular and Digital Pathology Innovators Xyall and Indica Labs Forge Global Collaboration to Transform Precision Oncology Workflows Read More »

Press Release: Indica Labs and Hamamatsu Photonics K.K. Announce Collaboration to Provide Optimized Integrated Digital Pathology Workflows

Albuquerque, NM and Hamamatsu City, Japan, – 14th October 2022 – Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and Hamamatsu Photonics K.K., a forerunner in whole slide imaging systems, announced an agreement to maintain long-term interoperability between Indica Labs’ HALO AP® software platform and Hamamatsu’s NanoZoomer family of high-speed, high-resolution scanners.

Press Release: Indica Labs and Hamamatsu Photonics K.K. Announce Collaboration to Provide Optimized Integrated Digital Pathology Workflows Read More »

Press Release: Leica Biosystems Announces Partnership with Indica Labs to Deliver Integrated Digital Pathology Workflow Solutions for Mutual Customers

Vista, CA – Sep 4, 2022, Leica Biosystems, a cancer diagnostics company and a global leader in workflow solutions, and Indica Labs, the industry-leading provider of computational and image management software in digital pathology, today announced a partnership focused on delivering compatible digital pathology workflow solutions.

Press Release: Leica Biosystems Announces Partnership with Indica Labs to Deliver Integrated Digital Pathology Workflow Solutions for Mutual Customers Read More »

Press Release: Indica Labs Announces Collaboration with The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD) for the Development of an AI-based Algorithm for the Automated Reporting of Lymph Node Status in Colon Cancer

Albuquerque, NM, and Glasgow, Scotland, – 30 August, 2022 – Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD), announced today an agreement to collaborate on the development of an AI-based digital pathology solution for the detection of cancer within lymph nodes from colorectal surgery cases.

Press Release: Indica Labs Announces Collaboration with The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD) for the Development of an AI-based Algorithm for the Automated Reporting of Lymph Node Status in Colon Cancer Read More »

Press Release: Deep Bio successfully integrates DeepDx® Prostate algorithm into HALO AP® platform from Indica Labs

Seoul, South Korea, and Albuquerque, NM – August 9, 2022 – Deep Bio, a company concentrating on SaMD (Software as a Medical Device) for digital pathology, is offering clinically validated, AI-based DeepDx® algorithms, and Indica Labs, a leading provider of computational pathology software and services, are excited to announce the successful integration of the DeepDx® Prostate algorithm into the HALO AP® platform from Indica Labs.

Press Release: Deep Bio successfully integrates DeepDx® Prostate algorithm into HALO AP® platform from Indica Labs Read More »

Scroll to Top